Proteasome Inhibitor [EPC]: Side Effects & Safety Data for 3 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Proteasome Inhibitor [EPC] includes 3 drugs with a combined 91,848 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
3
Drugs in Class
91,848
Combined Reports
All Proteasome Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| BORTEZOMIB | bortezomib | 47,710 | 7,318 | 14,626 | 15.3% |
| IXAZOMIB | NINLARO | 22,324 | 4,704 | 7,433 | 21.1% |
| CARFILZOMIB | KYPROLIS | 21,814 | 3,448 | 7,502 | 15.8% |
Common Side Effects in Proteasome Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Plasma cell myeloma | 12,170 | 2,675 |
| Off label use | 9,715 | 1,788 |
| Death | 6,312 | 6,301 |
| Neuropathy peripheral | 5,688 | 350 |
| Diarrhoea | 5,568 | 712 |
| Pneumonia | 4,619 | 1,129 |
| Thrombocytopenia | 4,311 | 885 |
| Fatigue | 4,261 | 450 |
| Drug ineffective | 3,960 | 747 |
| Nausea | 3,593 | 374 |